关注
Lingling Zhu
Lingling Zhu
lung cancer center, west china hospital
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu, X Jiang, A Matsui, L Zhu, ...
Nature communications 13 (1), 758, 2022
1302022
Exosomes as drug carriers in anti-cancer therapy
L Chen, L Wang, L Zhu, Z Xu, Y Liu, Z Li, J Zhou, F Luo
Frontiers in Cell and Developmental Biology 10, 728616, 2022
662022
MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway
LI Li, J Zhao, S Huang, Y Wang, L Zhu, Y Cao, J Xiong, J Deng
Gene 641, 240-247, 2018
592018
Emerging role of immunotherapy for colorectal cancer with liver metastasis
X Yu, L Zhu, J Liu, M Xie, J Chen, J Li
OncoTargets and therapy, 11645-11658, 2020
342020
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges
L Zhu, X Yu, L Wang, J Liu, Z Qu, H Zhang, L Li, J Chen, Q Zhou
Oncogenesis 10 (7), 47, 2021
332021
Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways
L Zhu, S Huang, J Li, J Chen, Y Yao, L Li, H Guo, X Xiang, J Deng, ...
Gene 742, 144556, 2020
312020
The promising role of miR-296 in human cancer
L Zhu, H Deng, J Hu, S Huang, J Xiong, J Deng
Pathology-Research and Practice 214 (12), 1915-1922, 2018
292018
The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers
L Zhu, J Liu, J Chen, Q Zhou
Journal of hematology & oncology 14, 1-19, 2021
282021
A comprehensive understanding of choroidal metastasis from lung cancer
Z Qu, J Liu, L Zhu, Q Zhou
OncoTargets and therapy, 4451-4465, 2021
192021
Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
Z Lingling, L Jiewei, W Li, Y Danli, Z Jie, L Wen, P Dan, P Lei, Z Qinghua
Pathology-Research and Practice 216 (4), 152852, 2020
192020
Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients
S Huang, L Zhu, Y Cao, L Li, Y Xie, J Deng, J Xiong
Oncotarget 8 (46), 80303, 2017
182017
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
L Zhu, X Yu, T Cao, H Deng, X Tang, Q Lin, Q Zhou
Acta Pharmaceutica Sinica B 13 (6), 2464-2482, 2023
162023
A spike protein S2 antibody efficiently neutralizes the Omicron variant
J Hu, X Chen, X Lu, L Wu, L Yin, L Zhu, H Liang, F Xu, Q Zhou
Cellular & molecular immunology 19 (5), 644-646, 2022
162022
Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: a systematic review and meta-analysis
L Zhu, G Ma, J Liu, Y Deng, Q Wu, W Chen, Q Zhou
Medicine 98 (16), e15069, 2019
122019
Updated Interpretation of the NCCN Clinical Practice Guidelines (Version 3. 2023) for Non-small Cell Lung Cancer.
ZHU Lingling, W Ting, WU Juan, Z Xiaoqian, WU Qiang, D Hanyu, ...
Chinese Journal of Lung Cancer 26 (6), 2023
92023
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
X Yu, L Zhu, T Wang, J Chen
Frontiers in Immunology 14, 1037945, 2023
82023
Tumor vessel normalization and immunotherapy in gastric cancer
X Yu, S He, J Shen, Q Huang, P Yang, L Huang, D Pu, L Wang, L Li, J Liu, ...
Therapeutic Advances in Medical Oncology 14, 17588359221110176, 2022
82022
Case report: anlotinib reverses nivolumab resistance in advanced primary pulmonary lymphoepithelioma-like carcinoma with FGFR3 gene amplification
Y Liu, L Long, J Liu, L Zhu, F Luo
Frontiers in oncology 11, 749682, 2021
72021
Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications
X Zhai, Y Lin, L Zhu, Y Wang, J Zhang, J Liu, L Li, X Lu
Cytokine & growth factor reviews 75, 101-109, 2024
62024
Robotic versus laparoscopic gastrectomy for gastric cancer in patients with obesity: systematic review and meta-analysis
X Yu, L Zhu, Y Zhang, Q Feng
Frontiers in Oncology 13, 1158804, 2023
62023
系统目前无法执行此操作,请稍后再试。
文章 1–20